TNFSF13B and pemphigus foliaceus: Additionally, the efficacy of anti‐B‐cell therapy targeting CD20 or B‐cell activating factor of the TNF family (BAFF) has been validated for the treatment of skin fibrotic diseases,119, 120 which suggests that targeting CD20 or BAFF could be a feasible method for treating PF.